Literature DB >> 31313045

Thoracic Duct Resection During Esophagectomy Does Not Contribute to Improved Prognosis in Esophageal Squamous Cell Carcinoma: A Propensity Score Matched-Cohort Study.

Taro Oshikiri1, Gosuke Takiguchi2, Susumu Miura2, Hironobu Goto3, Dai Otsubo3, Hiroshi Hasegawa2, Masashi Yamamoto2, Shingo Kanaji2, Kimihiro Yamashita2, Takeru Matsuda4, Yasuhiro Fujino3, Masahiro Tominaga3, Tetsu Nakamura2, Satoshi Suzuki5, Yoshihiro Kakeji2.   

Abstract

PURPOSE: Esophagectomy with extended lymphadenectomy remains the mainstay of treatment for localized esophageal squamous cell carcinoma (ESCC). Thoracic duct (TD) resection has been recommended as part of extended lymphadenectomy, although its merits are unclear. The aim of this two-institutional, matched-cohort study is to clarify whether TD resection improves prognosis in esophagectomy for ESCC. PATIENTS AND METHODS: In this two-institutional, matched-cohort study of 399 patients with ESCC who underwent McKeown esophagectomy between 2010 and 2014, the primary outcomes were overall survival (OS), disease-free survival (DFS), and cause-specific survival (CSS). Secondary outcomes were perioperative results and recurrence patterns.
RESULTS: Based on a propensity score, 122 TD-resected or 122 TD-preserved patients in all stages were selected (median follow-up 4.5 years). The 5-year OS, DFS, and CSS rates in the TD-resected versus TD-preserved groups were 49% versus 60%, 53% versus 57%, and 58% versus 70%, respectively, without any significant differences. Operative time for the thoracic procedure was significantly longer and the number of retrieved mediastinal nodes was significantly higher in the TD-resected group (P = 0.009 and 0.005, respectively). The rates of chylothorax and left recurrent laryngeal nerve (RLN) palsy were significantly higher in the TD-resected group (P = 0.041 and 0.018, respectively). There were no significant differences in rates of local or distant metastases between the two groups.
CONCLUSIONS: TD resection does not contribute to improve OS, DFS, or CSS in ESCC but increases incidence of chylothorax and left RLN palsy. Prophylactic TD resection should be avoided in esophagectomy for ESCC.

Entities:  

Mesh:

Year:  2019        PMID: 31313045     DOI: 10.1245/s10434-019-07627-x

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  4 in total

Review 1.  Traumatic Chylothorax: Approach and Outcomes.

Authors:  Shenise N Gilyard; Minhaj S Khaja; Abhishek K Goswami; Nima Kokabi; Wael E Saad; Bill S Majdalany
Journal:  Semin Intervent Radiol       Date:  2020-07-31       Impact factor: 1.513

2.  Perioperative safety and short-term efficacy of functional minimally invasive esophagectomy.

Authors:  Huibing Liu; Defeng Jin; Qian Wang; Zhaoqing Cui; Luchang Zhang; Yutao Wei
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

3.  Lymph-Directed Self-Immolative Nitric Oxide Prodrug for Inhibition of Intractable Metastatic Cancer.

Authors:  Taejeong Kim; Jeeyeon Suh; Jihoon Kim; Won Jong Kim
Journal:  Adv Sci (Weinh)       Date:  2022-01-05       Impact factor: 17.521

4.  Prognostic impact of thoracic duct lymph node metastasis in esophageal squamous cell carcinoma.

Authors:  Satoru Matsuda; Hirofumi Kawakubo; Hiroya Takeuchi; Shuhei Mayanagi; Tomoyuki Irino; Kazumasa Fukuda; Rieko Nakamura; Norihito Wada; Yuko Kitagawa
Journal:  Ann Gastroenterol Surg       Date:  2021-01-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.